Compare Cipta Sarana Medika Tbk. (DKHH) vs Lotte Chemical Titan Tbk. (FPNI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Lotte Chemical Titan Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Lotte Chemical Titan Tbk. trades at Rp418 (market cap 2.36T, 1.99M 24h volume). The key difference: Lotte Chemical Titan Tbk. is far larger — about 14.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 1.99M). Which is the better fit depends on your goals.
| DKHH | FPNI | |
|---|---|---|
Market Cap | 163.22B | 2.36T |
Volume | 3.92M | 1.99M |
Lot | 39.16K | 19.95K |
Turnover | 249.6M | 830.59M |
Average Price | 63.74 | 416.38 |
Value | 249.6M | 830.59M |
Indicative Equilibrium Price | 64 | 418 |
Indicative Equilibrium Volume | 77 | 1.12K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Lotte Chemical Titan Tbk.
PT. Lotte Chemical Titan Tbk. (the Company) was established in the Republic of Indonesia under the name of P.T. Indofatra Plastik Industri based on Notarial Deed No. 19 of Rukmasanti Hardjasatya, S.H., dated December 9, 1987. Subsequently, its name was changed to P.T. Fatrapolindo Nusa Industri based on Notarial Deed No. 53 dated July 18, 1988 of the same notary. The Company conduct in Bi-axially Oriented Polypropylene/ BOPP Film industry. Start the commercial operation on 1990 by one line production. Now, the corporate have load capacity 20.000 ton/year.
Read more on FPNI →
